Skip to main content

Posts

Showing posts from May, 2025

NVIDIA Stock (NVDA) Great Growth and Good Value (Q1 2026 Earnings)

NVIDIA Corporation (NASDAQ: NVDA) continues to solidify its position as a leader in the semiconductor industry, particularly in the realms of artificial intelligence (AI) and data center solutions. The company's recent Q1 2026 earnings report underscores its robust growth trajectory and financial strength, making it an attractive consideration for investors seeking both growth and value. In this article we will dive into NVIDIA recent earnings, stock performance & valuation, growth potential, and the risks investor should consider.

How Dividend Payout Ratio is Important

In the world of investing, dividends represent a share of profits distributed by a company to its shareholders. For many investors, especially those looking for steady income, dividends are a crucial part of their investment strategy. But while the dividend amount itself garners much attention, the dividend payout ratio is an equally, if not more, important metric that can reveal the sustainability and quality of those payments. Understanding the dividend payout ratio is essential for anyone who wants to make informed investment decisions.

Catalyst Pharmaceuticals Stock (CPRX) Strong Growth and Good Value in Q1 2025 Earnings

Catalyst Pharmaceuticals (NASDAQ: CPRX) continues to impress investors with its robust financial performance and promising growth prospects. The company's Q1 2025 earnings report highlights significant year-over-year growth in revenue and earnings per share (EPS), underscoring its strong position in the biopharmaceutical sector. With a focus on rare diseases and a strategic approach to product development and commercialization, Catalyst Pharmaceuticals presents a compelling investment opportunity. In this article we will dive into Catalyst Pharmaceuticals recent earnings, stock performance & valuation, growth potential, and the risks investor should consider.

Exelixis Stock (EXEL) Good Growth and Good Value in Q1 2025

Exelixis (NASDAQ: EXEL) has emerged as a standout performer in the healthcare sector, delivering exceptional financial results in Q1 2025. With robust revenue growth, significant earnings improvements, and a promising guidance, the company presents a compelling case for investors seeking both growth and value. In this article we will dive into Exelixis recent earnings, stock performance & valuation, growth potential, and the risks investor should consider.

Iren Limited Stock (IREN) Great Growth and Good Value in Q3 2025 Earnings

In the rapidly evolving sectors of cryptocurrency mining and high-performance computing (HPC), IREN Limited (NASDAQ: IREN) has emerged as a noteworthy player. The company's Q3 2025 earnings report highlights substantial growth, positioning it as a compelling investment opportunity. With significant year-over-year revenue increases and strategic expansions into AI cloud services, IREN demonstrates both robust performance and promising future prospects. In this article we will dive into IREN Limited recent earnings, stock performance & valuation, growth potential, and the risks investor should consider.

Short Term Trading Only Looks Good Until We Try It

On the surface, short term trading looks glamorous. We often see images of traders living luxurious lives, flashing profits from quick trades, or working just a few hours a day while supposedly making fortunes. In theory, the idea is enticing: make fast decisions, cash in quickly, and repeat. What’s not to love? Yet for most people, the harsh reality only becomes clear when they actually attempt short term trading themselves. Suddenly, what once looked like an easy money machine reveals itself as an incredibly difficult, stressful, and often financially draining endeavor.

On Holding Stock (ONON) Strong Growth and Good Value in Q1 2025

On Holding AG (NYSE: ONON) has emerged as a standout performer in the athletic footwear and apparel industry, demonstrating remarkable growth and resilience. With its innovative products and strategic market positioning, the company has captured the attention of investors and consumers alike. The recent Q1 2025 earnings report underscores On Holding's robust financial health and promising future prospects. In this article we will dive into On Holdings recent earnings, stock performance & valuation, growth potential, and the risks investor should consider.

Uber Technologies Stock (UBER) Good Growth and Good Value in Q1 2025

Uber Technologies Inc. (NYSE: UBER) has emerged as a standout performer in the tech sector, showcasing robust financial results and strategic expansions in Q1 2025. With a diversified portfolio encompassing ride-hailing, food delivery, freight, and emerging ventures like autonomous vehicles and international train services, Uber is redefining urban mobility. This article delves into Uber's recent performance, stock valuation, growth prospects, and potential risks, offering a comprehensive analysis for investors considering UBER stock.

High P/E Ratio Is Not Always Bad

In the world of investing, the price-to-earnings (P/E) ratio is one of the most frequently cited metrics when evaluating a company's stock. On the surface, it seems straightforward: a lower P/E ratio often suggests a stock is undervalued, while a higher P/E implies overvaluation. However, this simple interpretation can be misleading. A high P/E ratio is not always a red flag it can, in fact, signal a variety of positive factors about a company's future prospects.

Sezzle Stock (SEZL) Great Growth and Good Value in Q1 2025

Sezzle Inc. (NASDAQ: SEZL) has emerged as a standout performer in the fintech sector, particularly within the Buy Now, Pay Later (BNPL) industry. With its impressive Q1 2025 earnings, the company has demonstrated significant growth and value, making it an attractive option for investors seeking exposure to innovative financial services.

Oscar Health Stock (OSCR) Great Growth and Undervalue in Q1 2025

Oscar Health Inc. (NYSE: OSCR) has emerged as a notable player in the health insurance sector, leveraging technology to enhance healthcare accessibility and affordability. Despite facing challenges since its IPO, the company's recent financial performance indicates a promising turnaround. This article delves into Oscar Health's background, financial performance, stock valuation, growth prospects, and associated risks, providing a comprehensive overview for potential investors.

Understanding Cyclical Stocks

Investing in the stock market often requires a thorough understanding of various types of stocks and how they behave under different economic conditions. One category that frequently comes up in discussions about market timing and economic forecasting is cyclical stocks . These stocks are deeply influenced by macroeconomic trends, and understanding them can be the key to making informed investment decisions. This article delves into what cyclical stocks are, how they function, the risks and rewards associated with them, and strategies for investors.

Affirm Holdings (AFRM) Strong Growth and Good Value in Q3 2025 Earnings

Affirm Holdings Inc. (NASDAQ: AFRM), a leader in the Buy Now, Pay Later (BNPL) sector, has demonstrated impressive growth and financial improvement in its Q3 FY2025 earnings report. With a significant increase in revenue and a notable turnaround in earnings per share, Affirm's performance indicates a robust trajectory. This article delves into Affirm's recent financial results, stock performance, valuation, growth prospects, and associated risks, providing a comprehensive analysis for potential investors

Amazon Stock (AMZN) Good Growth and Good Value in Q1 2025

Amazon.com Inc. (NASDAQ: AMZN) has once again demonstrated its resilience and growth potential with a strong performance in the first quarter of 2025. Despite facing macroeconomic challenges, including tariff concerns and fluctuating consumer demand, Amazon's diversified business model and strategic investments continue to drive impressive financial results. This article delves into Amazon's Q1 2025 earnings, evaluates its stock performance, and explores the company's growth prospects and potential risks.

ADMA Biologics Stock (ADMA) Great Growth and Good Value in Q1 2025

ADMA Biologics (NASDAQ: ADMA) has emerged as a standout performer in the healthcare sector, demonstrating robust financial growth and operational efficiency. Following its Q1 2025 earnings report, the company continues to showcase its potential as a compelling investment opportunity, driven by strong revenue growth, expanding profit margins, and strategic initiatives.

Types of Stocks That Peter Lynch Categorized

Peter Lynch, the legendary mutual fund manager of the Fidelity Magellan Fund from 1977 to 1990, is one of the most revered figures in the world of investing. During his 13-year tenure, Lynch averaged an annual return of 29.2%, making the Magellan Fund one of the most successful mutual funds in history. What set Lynch apart was his unique ability to identify and invest in stocks that delivered outsized returns, many of which were underappreciated or overlooked by Wall Street. Rather than relying solely on complex financial models, Lynch favored a more intuitive and accessible approach to investing. His investment philosophy, detailed in books such as One Up on Wall Street and Beating the Street , revolves around understanding what you invest in, spotting opportunities in everyday life, and categorizing stocks into distinct types. Let’s explore the types of stocks Peter Lynch categorized and the characteristics he looked for in them.

Sea Limited (SE) Strong Growth and Good Value in Q1 2025

Sea Limited (NYSE: SE), the Singapore-based tech conglomerate behind Shopee, Garena, and SeaMoney, has emerged as one of the most compelling growth stories in Southeast Asia. With significant improvements in profitability, strong revenue growth, and a solid balance sheet in Q1 2025, Sea Limited presents a promising investment opportunity for those seeking exposure to the dynamic Southeast Asian digital economy.

Delcath Systems (DCTH) Strong Growth and Good Value in Q1 2025

Delcath Systems Inc. (NASDAQ: DCTH) has emerged as a standout performer in the healthcare sector, demonstrating remarkable growth and promising value. With its innovative liver cancer treatment, HEPZATO KIT, the company has achieved significant milestones, as reflected in its Q1 2025 earnings. This article delves into Delcath's impressive financial performance, stock valuation, growth potential, and the associated risks, providing a comprehensive analysis for investors. 

Krystal Biotech Stock (KRYS) Great Growth and Good Value in Q1 2025

Krystal Biotech Inc. (NASDAQ: KRYS) has emerged as a standout in the biotechnology sector, delivering impressive financial results in Q1 2025. Despite recent stock price fluctuations, the company's robust growth trajectory, innovative gene therapy platform, and solid financial metrics position it as a compelling investment opportunity. In this article we will dive into Krystal Biotech recent earnings, stock performance & valuation, growth potential, and the risks investor should consider.

Why You Shouldn't Exit the Market During a Bear Market

Investing in the stock market can be a rollercoaster of emotions. When the market is soaring, it's easy to feel like a financial genius. But when it plummets, entering what's known as a bear market, even seasoned investors can feel the panic start to set in. The instinct to pull your money out, sit on the sidelines, and wait for better times is understandable. However, history, psychology, and data all point to one clear message: you should not exit the market during a bear market. Here’s why staying invested is often the smarter, more profitable move in the long run.

CorMedix Stock (CRMD) Great Growth and Good Value in Q1 2025

CorMedix Inc. (NASDAQ: CRMD) has emerged as a standout performer in the biotech sector, showcasing remarkable financial growth and promising future prospects. The company's recent Q1 2025 earnings report highlights significant milestones, including a substantial increase in revenue and a transition to profitability. With a strong product lineup and favorable market conditions, CorMedix presents a compelling investment opportunity.

Symbotic (SYM) Strong Growth and Undervalue in Q2 2025

In the rapidly evolving landscape of warehouse automation, Symbotic Inc. (NASDAQ: SYM) has emerged as a prominent player, delivering innovative AI-powered robotics solutions to major retailers. Despite recent stock volatility, the company's robust financial performance and strategic partnerships suggest significant growth potential. This article delves into Symbotic's recent earnings, stock performance, valuation, growth prospects, and associated risks to the company.

TransMedics Group (TMDX) Strong Growth and Good Value in Q1 2025

TransMedics Group Inc. (NASDAQ: TMDX) has emerged as a standout performer in the medical technology sector, delivering robust financial results and demonstrating significant growth potential. The company's Q1 2025 earnings report highlights its impressive revenue and earnings growth, driven by the increasing adoption of its innovative Organ Care System (OCS). This article delves into Transmedics recent financial results, stock performance, growth prospects, and the risks investor should consider.

Hold Your Stock as Long as the Fundamental is Still Good

Investing in the stock market is a journey that tests both your financial knowledge and emotional resilience. Among the countless strategies available, one timeless principle stands out for long-term success: “Hold your stock as long as the fundamental is still good.” This simple, yet powerful guideline has been echoed by some of the world’s most successful investors, including Warren Buffett and Peter Lynch. Understanding this principle and how to apply it can be the difference between building lasting wealth and falling victim to market noise.

Novo Nordisk Stock (NVO) Good Growth and Good Value in Q1 2025

Novo Nordisk (NYSE: NVO) has emerged as a prominent player in the pharmaceutical industry, particularly in the treatment of diabetes and obesity. Despite facing challenges such as increased competition and market fluctuations, the company's robust financial performance and strategic initiatives have positioned it as a compelling investment opportunity. This article delves into Novo Nordisk's recent financial results, stock performance, growth prospects, and the risks investor should consider.

MercadoLibre Stock (MELI) Strong Growth and Good Value in Q1 2025

MercadoLibre (NASDAQ: MELI), often dubbed the “Amazon of Latin America,” has once again demonstrated its resilience and growth potential with a robust Q1 2025 earnings report. As the leading e-commerce and fintech platform in the region, MercadoLibre continues to capitalize on the digital transformation sweeping across Latin America. This article delves into the company's recent performance, stock valuation, growth prospects, and the risks investors should consider.

Why a Lot of People Fail in Investing

Investing is often portrayed as a straightforward path to financial success: buy low, sell high, and watch your wealth grow. Yet, despite the simplicity of this concept, a large number of people fail when they venture into investing. From emotional decision-making to a lack of education, there are many reasons why so many stumble along the way. Understanding these pitfalls can help aspiring investors navigate the markets with greater confidence and success.

Advanced Micro Devices (AMD) Strong Growth and Good Value in Q1 2025

Advanced Micro Devices (NASDAQ: AMD) has emerged as a formidable player in the semiconductor industry, showcasing impressive growth and innovation. The company's Q1 2025 earnings report highlights its robust performance, driven by advancements in artificial intelligence (AI) and data center technologies. Despite facing geopolitical challenges and market volatility, AMD's strategic initiatives and strong fundamentals position it as a compelling investment opportunity. In this article we will dive into AMD’s recent earnings, stock performance, growth potential, and the risks investors should consider.​

Hims & Hers Health (HIMS) Strong Growth and Good Value in Q1 2025

Hims & Hers Health Inc. (NYSE: HIMS) has emerged as a standout performer in the telehealth sector, delivering exceptional growth and solidifying its position as a leader in digital healthcare. The company's Q1 2025 earnings report showcased significant revenue and earnings growth, reflecting its successful telehealth business expansion. As the demand for convenient and personalized healthcare solutions continues to rise, Hims & Hers is well-positioned to capitalize on these trends. In this article we will dive into Hims & Hers recent earnings, stock performance, growth potential, and the risks investors should consider.​

Stocks Can Be a Hedge Against Inflation

Inflation is one of the most significant long-term risks for investors. It erodes purchasing power, raises the cost of living, and can diminish the value of savings if they’re not invested wisely. During inflationary periods, many investors search for ways to protect their wealth, turning to commodities, real estate, and Treasury Inflation-Protected Securities (TIPS). However, one of the most overlooked yet powerful hedges against inflation is the stock market. Despite its volatility, investing in stocks can offer a reliable means to outpace inflation over time. Here's why.

Travere Therapeutics Stock (TVTX) Great Growth and Good Value in Q1 2025

Travere Therapeutics (NASDAQ: TVTX) has emerged as a standout performer in the biotech sector, delivering impressive growth and capturing investor attention. With a focus on rare kidney and metabolic diseases, the company's recent financial results and strategic advancements suggest a promising trajectory. In this article we will dive into Travere’s recent earnings, stock performance, growth potential, and the risks investors should consider.​

Eli Lilly Stock (LLY) Strong Growth and Good Value in Q1 2025

Eli Lilly & Co. (NYSE: LLY) continues to solidify its position as a leading pharmaceutical company, demonstrating robust financial performance in Q1 2025. Despite recent market fluctuations, the company's strong fundamentals and strategic initiatives suggest a promising outlook for investors. In this article we will dive into Eli Lylly recent earnings, stock performance, growth potential, and the risks investors should consider.​

Defensive Sector in Recession Time

When the economic landscape darkens and recession clouds loom, investors naturally seek refuge in safer corners of the stock market. While no sector is completely immune to the effects of an economic downturn, the defensive sector has long been regarded as a relatively stable shelter. In times of financial uncertainty, companies that provide essential goods and services tend to maintain consistent revenue and performance, making them attractive to risk-conscious investors. In this article, we’ll explore the nature of the defensive sector, why it performs better during recessions, which industries fall under this category, and how to approach investing in defensive stocks when the economy turns south.

Zeta Global Stock (ZETA) Strong Growth and Undervalue in Q1 2025

Zeta Global Holdings Corp. (NYSE: ZETA), a leading AI-driven marketing technology company, has demonstrated robust growth in Q1 2025, positioning itself as an attractive investment opportunity. With significant revenue increases, improved profitability metrics, and a compelling valuation, Zeta Global is poised for continued success in the dynamic marketing technology landscape.

Robinhood Markets (HOOD) Strong Growth and Good Value in Q1 2025

Robinhood Markets Inc. (NASDAQ: HOOD) has emerged as a formidable player in the financial services sector, delivering impressive growth and solidifying its position as a compelling investment opportunity. The company's Q1 2025 earnings report underscores its robust financial performance, marked by significant increases in revenue and earnings per share. With a strategic focus on innovation and expanding its user base, Robinhood continues to redefine the landscape of retail investing.

Keeping the Winner is Important in Stock Investing

When it comes to stock investing, much of the focus tends to be on identifying the right stocks to buy. While selecting the right stock is crucial, an often overlooked but equally vital component of long-term investing success is knowing which stocks to hold on to , particularly the winners. “Keeping the winner” refers to the strategy of continuing to hold high-performing stocks rather than selling them too early. This approach, though emotionally challenging, can be the key to compounding wealth and achieving above-average returns in the stock market.

Meta Platforms Stock (META) Strong Growth and Good Value (Q1 2025 Earnings)

Meta Platforms Inc. (NASDAQ: META), the parent company of Facebook, Instagram, and WhatsApp, has demonstrated robust financial performance in the first quarter of 2025. With significant year-over-year growth in revenue and earnings, coupled with strategic investments in artificial intelligence (AI) and augmented reality (AR), Meta continues to solidify its position as a leader in the tech industry. This article provides an in-depth analysis of Meta's recent financial results, stock performance, growth prospects, and potential risks, offering insights for investors considering META stock.​